NCT05258279 2024-08-28
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
Juntendo University
Phase 2 Active not recruiting
Clinical Trials
3 trialsNCT04012619 2023-08-03
Anlotinib Hydrochloride Combined With AP in Stage IIIB/IIIC/IV Non-squamous Non-small-cell Lung Cancer
Sichuan University
Phase 1 Completed
NCT04453423 2020-07-01
Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown